Skip to content
Disclosery

Tower Research Capital LLC (TRC): DRUG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Tower Research Capital LLC (TRC) on DRUG, newest first. How the timeline and the estimate are built.

Tower Research Capital LLC (TRC) held 1,011 DRUG shares at 2026-06-30 per its 13F-HR filed 2026-08-11.

the latest 13F is the newest step

  1. period ended2026-06-30
    13F 1,011 shares
    Change vs previous 13F +414 shares

    <0.01% of the 13F portfolio, value $70,972.

    13F-HR 0001533421-26-000008 filed by Tower Research Capital LLC (TRC)
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2026-03-31
    13F 597 shares
    Change vs previous 13F -485 shares

    <0.01% of the 13F portfolio, value $43,563.

    13F-HR 0001533421-26-000006 filed by Tower Research Capital LLC (TRC)
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-12-31
    13F 1,082 shares
    Change vs previous 13F +811 shares

    <0.01% of the 13F portfolio, value $84,439.

    13F-HR 0001533421-26-000004 filed by Tower Research Capital LLC (TRC)
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2025-09-30
    13F 271 shares
    Change vs previous 13F not available

    <0.01% of the 13F portfolio, value $16,439.

    13F-HR 0001533421-25-000019 filed by Tower Research Capital LLC (TRC)
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).